Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tobramycin Inhalation Powder vs Solution in Cystic Fibrosis (EAGER)
NCT00388505Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2006
- Primary completion
- Mar 2009
- Countries
- 14
01
Overview
Phase 3, randomised, open-label trial of tobramycin in Pseudomonas aeruginosa infection, sponsored by Novartis. Started Feb 2006; status: completed.
02
Drugs
tobramycin
03
Conditions
Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT00388505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00388505.